A PHARMACEUTICAL COMPOSITION FOR TREATING AND DIAGNOSING A DISORDER ASSOCIATED WITH PEROXISOMAL BIOGENESIS AND FUNCTION

摘要

The invention relates to a pharmaceutical composition for treating or diagnosing a disorder associated with production of peroxisome in a cell, comprising a polypeptide which has cysteine protease activity and directly processes peroxisomal enzymes targeted by PTS1 or PTS2 signals. Preferably, the polypeptide is encoded by Tysnd1.